• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Episode 10: Glaucoma 360: What's new for 2020

Article
Conferences|GLAUCOMA 360

Ophthalmology Times EyePod

With Glaucoma 360 scheduled to kick off in San Francisco Feb. 6 through 8, Glaucoma Research Foundation President/CEO Thomas M. Brunner discusses what attendees can expect as well as new additions to the organization’s signature event this year. 

Listen to more EyePod content here 

Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Deb Ristvedt, DO's CIME 2024 Talk Highlights Innovations in Treating Glaucoma via the Trabecular Meshwork
Dr. Inder Paul Singh's Insights: Improving Glaucoma Outcomes with Early Intervention and Reduced Medication
CIME 2024: Neda Shamie, MD, reports on a morning session packed with refractive surgery options, retina, glaucoma, and a 'mite-y' Demodex discussion
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Related Content
Alcon to acquire Belkin Vision in deal estimated at $335 million

Alcon to acquire Belkin Vision in deal estimated at $335 million

Article
EyePod: Transforming the MIGS pipeline into clinical practice

EyePod: Transforming the MIGS pipeline into clinical reality

Podcast
iStent MIGS devices associated with less visual field progression in glaucoma compared with medical therapy

iStent MIGS devices associated with less visual field progression in glaucoma compared with medical therapy

Article
Modifying and optimizing a new era of glaucoma surgeries

Modifying and optimizing a new era of glaucoma surgeries

Podcast
ARVO 2024: Researchers detail novel glaucoma shunt

ARVO 2024: Researchers detail novel glaucoma shunt

Article
Adherence and tolerability are key in treatment of hypertension and glaucoma

Adherence and tolerability are key in treatment of hypertension and glaucoma

Article
© 2024 MJH Life Sciences

All rights reserved.